BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2554135)

  • 1. DNA topoisomerases and models of sister-chromatid exchange.
    Dillehay LE; Jacobson-Kram D; Williams JR
    Mutat Res; 1989 Nov; 215(1):15-23. PubMed ID: 2554135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between sister chromatid exchange frequencies and replicon sizes. A model for the mechanism of SCE production.
    Cleaver JE
    Exp Cell Res; 1981 Nov; 136(1):27-30. PubMed ID: 6271563
    [No Abstract]   [Full Text] [Related]  

  • 3. A replication model for sister-chromatid exchange.
    Painter RB
    Mutat Res; 1980 May; 70(3):337-41. PubMed ID: 7383040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8.
    Cortés F; Piñero J; Palitti F
    Mutat Res; 1993 Aug; 288(2):281-9. PubMed ID: 7688089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of sister chromatid exchanges by inhibitors of topoisomerases.
    Lim M; Liu LF; Jacobson-Kram D; Williams JR
    Cell Biol Toxicol; 1986 Dec; 2(4):485-94. PubMed ID: 2855799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC; Camacho-Carranza R
    Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Bromodeoxyuridine-dependent increase in sister chromatid exchange formation in Bloom's syndrome is associated with reduction in topoisomerase II activity.
    Heartlein MW; Tsuji H; Latt SA
    Exp Cell Res; 1987 Mar; 169(1):245-54. PubMed ID: 3028845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of sister-chromatid exchange.
    Wilson DM; Thompson LH
    Mutat Res; 2007 Mar; 616(1-2):11-23. PubMed ID: 17157333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
    Snapka RM
    NCI Monogr; 1987; (4):55-60. PubMed ID: 2819732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sister chromatid exchange induced by DNA topoisomerases poisons in late replicating heterochromatin: influence of inhibition of replication and transcription.
    Piñero J; López Baena M; Ortiz T; Cortés F
    Mutat Res; 1996 Jul; 354(2):195-201. PubMed ID: 8764948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase II plays an essential role as a swivelase in the late stage of SV40 chromosome replication in vitro.
    Ishimi Y; Sugasawa K; Hanaoka F; Eki T; Hurwitz J
    J Biol Chem; 1992 Jan; 267(1):462-6. PubMed ID: 1309747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The interrelation between changes in the structural organization of replicon clusters, a retarded fork displacement rate and the high level of spontaneous SCEs in form II of xeroderma pigmentosum].
    Barenfel'd LS; Nergadze SG; Pleskach NM; Mikhel'son VM
    Tsitologiia; 1992; 34(6):88-94. PubMed ID: 1455562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Okadaic acid, a protein phosphatase inhibitor, induces sister-chromatid exchanges depending on the presence of bromodeoxyuridine.
    Tohda H; Nagao M; Sugimura T; Oikawa A
    Mutat Res; 1993 Oct; 289(2):275-80. PubMed ID: 7690896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular roles of DNA topoisomerases: a molecular perspective.
    Wang JC
    Nat Rev Mol Cell Biol; 2002 Jun; 3(6):430-40. PubMed ID: 12042765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases.
    Cortés F; Piñero J; Ortiz T
    Mutat Res; 1993 Oct; 303(2):71-6. PubMed ID: 7692280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle dependence of sister chromatid exchange induction by DNA topoisomerase II inhibitors in Chinese hamster V79 cells.
    Dillehay LE; Denstman SC; Williams JR
    Cancer Res; 1987 Jan; 47(1):206-9. PubMed ID: 3024815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents.
    Anderson RD; Berger NA
    Mutat Res; 1994 Aug; 309(1):109-42. PubMed ID: 7519727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Poisons of DNA topoisomerases I and II].
    Charcosset JY; Soues S; Laval F
    Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nalidixic acid-resistant V79 cells with reduced DNA topoisomerase II activity and amplification prone phenotype.
    Di Leonardo A; Maddalena A; Cavolina P
    Mutat Res; 1992 Oct; 269(2):319-27. PubMed ID: 1383716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sister chromatid exchange induction and the course of DNA duplication, two mechanisms of sister chromatid exchange induction by ENU and the role of BrdU.
    Rodríguez-Reyes R; Morales-Ramírez P
    Mutagenesis; 2003 Jan; 18(1):65-72. PubMed ID: 12473737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.